Innovative therapeutics

Investors

SEC Filings

NASDAQBMRN
FormDescriptionDateFormat
4Statement of changes in beneficial ownership of securitiesMar 26, 2019View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 25, 2019View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 21, 2019View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 21, 2019View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 21, 2019View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 19, 2019View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 19, 2019View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 19, 2019View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 19, 2019View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 19, 2019View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 19, 2019View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 19, 2019View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 14, 2019View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 13, 2019View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 8, 2019View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 6, 2019View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 5, 2019View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 5, 2019View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 5, 2019View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 5, 2019View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 5, 2019View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 5, 2019View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesFeb 28, 2019View HTMLDownload DOCDownload PDF
10-KAnnual report which provides a comprehensive overview of the company for the past yearFeb 28, 2019View HTMLDownload DOCDownload PDFDownload XLSView XBRLDownload XBRL
4Statement of changes in beneficial ownership of securitiesFeb 22, 2019View HTMLDownload DOCDownload PDF
1-25      26-50      51-75      76-93

BioMarin

Diseases

Lysosomal Storage Disorders (MPS I, MPS IVA, MPS VI, CLN2 disease) PKU, LEMS

Products

Palynziq™
Brineura™
Vimizim®
Kuvan®
Naglazyme®
Aldurazyme®
Firdapse®

Patient/Physician Support Contact Information

BioMarin RareConnections
Tel: 866.906.6100
Fax: 888.863.3361
E-mail: support@biomarin-rareconnections.com

Global Medical Information

Contact Global Medical Information